Light Chain Bioscience
PrivateLast Round
VC Round
May 11, 2016
Total Funding Raised
$196.6M
Company Overview
Light Chain Bioscience is a drug discovery company that develops multi-specific antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Light Chain Bioscience Comparables
Compare Light Chain Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymeworks Inc. | 81% | |
| Xencor, Inc. | 79% | |
| Merus N.V. | 79% |
Light Chain Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 11, 2016 | ||||
| VC Round | Jan 13, 2016 | ||||
| Series B | Feb 18, 2014 | ||||
| Series A | Apr 28, 2000 |
Key People
Founding team and executive leadership
Light Chain Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BZ Bank Aktiengesellschaft | Series B |
| Rosetta Capital | Series B |
| Lombard Odier | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 303% MoM, reaching 4.4K.
- Feb 11, 2026
Grew 43% QoQ, from 53 to 76 employees.
Light Chain Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access